One Size Does Not Fit All: Pharmacogenomics in Precision Medicine

Sandosh Padmanabhan and Andrew Morrow will discuss how pharmacogenomics methods improve precision medicine for cardiovascular disease treatment.

The Scientist Creative Services Team
Feb 10, 2021

FREE Webinar

Friday, February 26, 2021
11:30 AM- 1:00 PM Eastern Time

Register Now

To improve disease outcomes in numerous fields of medicine, researchers strive to predict how a patient will react to certain medications. Using pharmacogenomics methods, scientists identify genetic markers that predict drug responses and use that information to customize patient treatment plans. In this webinar from The Scientist, Sandosh Padmanabhan and Andrew Morrow will discuss how they use pharmacogenomics to improve precision medicine for cardiovascular diseases.

Register Now

Meet the Speakers:

Sandosh Padmanabhan, MD, PhD
Professor, Cardiovascular Genomics and Therapeutics
Institute of Cardiovascular and Medical Sciences
Associate, School of Medicine, Dentistry, and Nursing
University of Glasgow

Andrew Morrow, PhD
Clinical Research Fellow
Institute of Cardiovascular and Medical Sciences
University of Glasgow


April 2021

Advancing Against Metastasis

Cancer cells can spread early and lie dormant for years


Sponsored Product Updates

Synthego Launches Eclipse Platform to Accelerate Research and Development of Next-generation Medicines
First-of-its-kind Platform Enables Scalable CRISPR-based Cell Engineering
Making the Most Out of the Ultraviolet Laser: How BD Horizon Brilliant™ Ultraviolet Dyes Drive Discovery
Flow cytometry is a binary system, where cells are either positive or negative for a specific marker when using an appropriate fluorescent dye to detect a specific antigen.
The Power of Discovery
Harnessing insights into heritable mutations from whole-exome sequencing data.
Using Multicolor Flow Cytometry for COVID-19 Research
Designing multicolor flow cytometry panels to characterize immunological changes observed in COVID-19 patients.